S. Vickers

Metabolic disposition studies on simvastatin, a cholesterol-lowering prodrug.

S. Vickers, C A Duncan, I W Chen et al. · Drug Metabolism and Disposition · 1990 · 244 citations

In vitro and in vivo biotransformation of simvastatin, an inhibitor of HMG CoA reductase.

S. Vickers, C A Duncan, Kamlesh P. Vyas et al. · Drug Metabolism and Disposition · 1990 · 154 citations

The physiological disposition of lovastatin.

D E Duggan, I W Chen, W.F. Bayne et al. · Drug Metabolism and Disposition · 1989 · 124 citations

Development of Orally Active Oxytocin Antagonists:  Studies on 1-(1-{4-[1-(2-Methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2- methoxybenzoyl}piperidin-4-yl)-1,4-dihydrobenz[<i>d</i>][1,3]oxazin-2-one (L-372,662) and Related Pyridines

Ian M. Bell, Jill M. Erb, Roger Freidinger et al. · Journal of Medicinal Chemistry · 1998 · 60 citations · Full text

Pharmacotherapy, Orally Active Oxytocin, Experimental Pharmacology +16

Metabolism of carbidopa (1-(-)-alpha-hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid monohydrate), an aromatic amino acid decarboxylase inhibitor, in the rat, rhesus monkey, and man.

S. Vickers, Emiko Stuart, J. R. Bianchine et al. · PubMed · 1974 · 40 citations

Pharmacotherapy, Experimental Pharmacology, Pharmaceutical Chemistry +18